← Back to Search

Antiretroviral

B/F/TAF for HIV

Phase 4
Waitlist Available
Research Sponsored by Tulika Singh, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 48
Awards & highlights

Study Summary

This trial assesses patient satisfaction and medication tolerability in HIV-1 infected adults over 65 who switch to a fixed-dose combination regimen of bictegravir/emtricitabine/tenofovir alafenamide.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 48
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 48 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in overall quality of life as characterized by a change in total satisfaction scale as measured by the HIVDQoL survey.
Improvement in treatment satisfaction by a change in total satisfaction scale as measured by the HIVTSQ survey.
Secondary outcome measures
Percentage of Participants experiencing Adverse Events (AEs) through End of Study (Week 48)
Percentage of all participants who have plasma HIV-1 RNA Viral Load < 50 c/mL at W24
Percentage of all participants who have plasma HIV-1 RNA Viral Load < 50 c/mL at end of study
+1 more

Side effects data

From 2023 Phase 4 trial • 28 Patients • NCT03797014
18%
Upper respiratory tract infection
7%
Abdominal pain
7%
Abscess, extremity
7%
Back pain
7%
Headache
7%
Hypertension
7%
Nausea
7%
Rash
100%
80%
60%
40%
20%
0%
Study treatment Arm
B/F/TAF

Trial Design

1Treatment groups
Experimental Treatment
Group I: B/F/TAFExperimental Treatment1 Intervention
B/F/TAF for 48 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
B/F/TAF
2016
Completed Phase 4
~4900

Find a Location

Who is running the clinical trial?

Tulika Singh, MDLead Sponsor
Gilead SciencesIndustry Sponsor
1,082 Previous Clinical Trials
842,791 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age
Tulika Singh, MD 2021. "Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05147740.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top